Wednesday, 20 November 2013

Turkey Pharmaceuticals and Healthcare Report Q1 2014

Business Monitor International Market Research Reports
Market Reports Online XML Feed 
Acquire Clients Globally!

Attention Advertisers: What's your CPA? Have Us Acquire Additional Clients for You Utilizing International, Localized PPC on AdWords, Bing, & Facebook Exchange!
From our sponsors
Turkey Pharmaceuticals and Healthcare Report Q1 2014
Nov 20th 2013, 00:00

Price: $ 1295  

BMI View: Despite a challenging pricing and reimbursement situation, BMI still believes the market is attractive in the long term as higher y-o-y growth rates return from 2013/14. In contrast to European markets where manufacturers can expect to achieve higher prices, but with a stagnant growth outlook, Turkey offers strong growth potential if drugmakers are able to accept a price that is considerably below the European average and turn a profit on the low margins available. Headline Expenditure Projections ? Pharmaceuticals: TRY16.39bn (US$9.11bn) in 2012 to TRY17.16bn (US$8.89bn) in 2013; +4.7% in local currency and -2.4% US dollar terms. Local currency forecast unchanged from previous quarter. ? Healthcare: TRY96.98bn (US$53.88bn) in 2012 to TRY109.66bn (US$56.82bn) in 2013; +13.1% in ...

Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/295124.html

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment